Fig. 7From: Model-based evaluation of the impact of prophylactic vaccination applied to Ebola epidemics in Sierra Leone and Democratic Republic of CongoImpact of additional vaccine efficacy in the form of 50% reduction in infectiousness and case fatality rateBack to article page